Honored to receive the Dr. Wesley J. Miller Education Scholar Award.
Grateful to my UMN Heme/Onc & Transplantation mentors and colleagues for their guidance, support, and example.
This is a meaningful reminder to keep learning, teaching, and paying it forward.
ASCO 2026 was even more special with my fellowship colleagues and mentors. Grateful for the teaching, support, guidance,and friendship that make this journey so meaningful.
Lucky to learn from and grow with such an amazing group.
@UMNHOT@UMNCancer#ASCO26#Oncology#Mentorship
One of the best parts of ASCO 2026 was reconnecting with mentors, teachers, friends, and colleagues from different stages of my journey.
Grateful for the conversations, encouragement, and reminders that none of us gets here alone.
Pay it forward. 🌱
#ASCO26#Oncology#MedEd
Drugging the “undruggable.” Incredible to see a KRAS-targeted approach showing meaningful survival benefit in pancreatic cancer — a disease where progress has been painfully hard. This feels like a real step forward. #ASCO26#PancreaticCancer#KRAS
#Ambition is a great motivator - until it leads to #burnout
🚗Engine problem (physical) or fuel (motivation)?
🏃🏽♀️ Chasing achievement - or meaning?
🏅Who defines my success?
⚡️What energizes me - can I do mostly that?
#CareerDevelopment#Leadership
https://t.co/kCf9flvpsl?
🚨🚨🚨
RASOLUTE-302 Ph3 is POSITIVE
"Daraxonrasib demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy, with a hazard ratio of 0.40 (p < 0.0001)".... WOW!
AMAZING news for patients with #PancreaticCancer
The RAS Revolution is ON!!
https://t.co/I59NNWRB1O
Just published in Frontiers in Oncology — a case of gBRCA2 metastatic rectal high-grade NEC with a durable near-CR on talazoparib.
Grateful to @guptaarjun90@EAntonarakis
https://t.co/LT1RZmb44Z
#GIOnc#NEC#BRCA2#PARP
I hear about this. This is not uncommon and it bothers me:
Patient has cancer which is getting worse and causing pain
Waits days for doctors appointment
See the doctor. Scans ordered.
But now waits days for an appointment slot to get the scans
Scan is done and shows the cancer has worsened. Doctor prescribes new treatment
Waits for days as insurance denies new treatment. Peer to peer call needed. Finally, treatment is approved.
Waits for days again because chemotherapy appointments are backed up.
Finally, the patient receives the treatment.
But a month has passed.
The cancer has progressed more.
All of this with good private insurance.
Imagine without.
Oncology has advanced rapidly. Our medicines are very specialized. They require a lot of time, expertise, resources. Oncologists are stretched thin. It’s not the type of work that you can easily fill without compromising care. Many patients receive complex chemo and when there is a complication they end up without access to specialized care. We need to expand the oncology work force and limit the burnout that is causing good oncologists to leave patient care for other jobs or retire.
There is no question we have made remarkable progress against cancer. And several promising new treatments are on the horizon. Will we have the resources to administer them safely and to all those who need it?
2 bonus quotes for the weekend:
"As you start to walk on the way, the way appears."--Rumi, 13th Century.
"“Be happy for this moment. This moment is your life.”--Omar Khayyam, 11th Century.
Just watched A Complete Unknown—absolutely masterful! I’ve always been a huge fan of Dylan, and now this movie has quickly become one of my all-time favorites too!
https://t.co/nvxWGPzGT6